EGF and ovarian carcinoma: Indeed, it has been shown that a neutralizing anti-EGF antibody can suppress the formation of spheroid in ascites mediated by the attenuated expression of ITGA5 in floating ovarian cancer cells, leading to the prolonged survival period [80].